Advisornet Financial’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298K | Buy |
6,133
+1,060
| +21% | +$51.6K | 0.02% | 480 |
|
|
2025
Q1 | $173K | Buy |
5,073
+2,595
| +105% | +$88.3K | 0.01% | 583 |
|
|
2024
Q4 | $97.5K | Buy |
2,478
+1,181
| +91% | +$46.5K | 0.01% | 692 |
|
|
2024
Q3 | $60.9K | Buy |
1,297
+197
| +18% | +$9.26K | ﹤0.01% | 845 |
|
|
2024
Q2 | $59.4K | Sell |
1,100
-60
| -5% | -$3.24K | 0.01% | 764 |
|
|
2024
Q1 | $79.1K | Buy |
1,160
+135
| +13% | +$9.2K | 0.01% | 694 |
|
|
2023
Q4 | $64.2K | Hold |
1,025
| – | – | 0.01% | 747 |
|
|
2023
Q3 | $46.5K | Sell |
1,025
-250
| -20% | -$11.3K | ﹤0.01% | 803 |
|
|
2023
Q2 | $71.6K | Buy |
1,275
+750
| +143% | +$42.1K | 0.01% | 724 |
|
|
2023
Q1 | $23.7K | Hold |
525
| – | – | ﹤0.01% | 1019 |
|
|
2022
Q4 | $21.3K | Sell |
525
-2
| -0.4% | -$81 | ﹤0.01% | 1036 |
|
|
2022
Q3 | $34K | Hold |
527
| – | – | ﹤0.01% | 952 |
|
|
2022
Q2 | $32K | Sell |
527
-33
| -6% | -$2K | ﹤0.01% | 988 |
|
|
2022
Q1 | $35K | Buy |
560
+25
| +5% | +$1.56K | ﹤0.01% | 1069 |
|
|
2021
Q4 | $41K | Sell |
535
-490
| -48% | -$37.6K | ﹤0.01% | 1067 |
|
|
2021
Q3 | $115K | Buy |
1,025
+13
| +1% | +$1.46K | 0.01% | 737 |
|
|
2021
Q2 | $164K | Hold |
1,012
| – | – | 0.01% | 642 |
|
|
2021
Q1 | $123K | Buy |
1,012
+960
| +1,846% | +$117K | 0.01% | 685 |
|
|
2020
Q4 | $8K | Buy |
52
+50
| +2,500% | +$7.69K | ﹤0.01% | 1319 |
|
|
2020
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1725 |
|
|
2020
Q2 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1773 |
|